BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37861906)

  • 1. Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study.
    Petrova NV; Emelyanova AG; Tarasov SA; Aparin PG; Ledov VA
    Bull Exp Biol Med; 2023 Sep; 175(5):649-652. PubMed ID: 37861906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
    Gómez-Lus ML; García Y; Valero E; Amores R; Fuentes F
    Rev Esp Quimioter; 2000 Sep; 13(3):306-13. PubMed ID: 11086282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
    Woodnutt G; Berry V
    Antimicrob Agents Chemother; 1999 Jan; 43(1):29-34. PubMed ID: 9869561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae.
    Garau J
    Clin Microbiol Infect; 2004 Apr; 10 Suppl 2():28-35. PubMed ID: 14759231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice.
    Gisby J; Wightman BJ; Beale AS
    Antimicrob Agents Chemother; 1991 May; 35(5):831-6. PubMed ID: 1854164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae.
    Anon JB
    Am J Med; 2004 Aug; 117 Suppl 3A():23S-28S. PubMed ID: 15360094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V; Hoover J; Singley C; Woodnutt G
    Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
    Parra A; Ponte C; Cenjor C; García-Olmos M; Giménez MJ; Aguilar L; Soriano F
    Int J Antimicrob Agents; 2004 Jan; 23(1):25-31. PubMed ID: 14732310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
    Woodnutt G; Berry V
    Antimicrob Agents Chemother; 1999 Jan; 43(1):35-40. PubMed ID: 9869562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004.
    Yalçin I; Gürler N; Alhan E; Yaman A; Turgut M; Celik U; Akçakaya N; Camcioğlu Y; Diren S; Yildirim B
    Eur J Pediatr; 2006 Sep; 165(9):654-7. PubMed ID: 16602003
    [No Abstract]   [Full Text] [Related]  

  • 12. Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance.
    Allan RN; Morgan S; Brito-Mutunayagam S; Skipp P; Feelisch M; Hayes SM; Hellier W; Clarke SC; Stoodley P; Burgess A; Ismail-Koch H; Salib RJ; Webb JS; Faust SN; Hall-Stoodley L
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2456-66. PubMed ID: 26856845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis.
    Anon JB; Berkowitz E; Breton J; Twynholm M
    Am J Otolaryngol; 2006; 27(4):248-54. PubMed ID: 16798401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.
    Sánchez Navarro A
    Clin Pharmacokinet; 2005; 44(11):1097-115. PubMed ID: 16231964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    Anon JB; Ferguson B; Twynholm M; Wynne B; Berkowitz E; Poole MD
    Ear Nose Throat J; 2006 Aug; 85(8):500, 502, 504 passim. PubMed ID: 16999056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2375-9. PubMed ID: 9736566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    Torumkuney D; Papaparaskevas J; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v36-v42. PubMed ID: 29659884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of amoxicillin-clavulanate against penicillin-resistant Streptococcus pneumoniae in an experimental respiratory infection model in rats.
    Smith GM; Slocombe B; Abbott KH; Mizen LW
    Antimicrob Agents Chemother; 1998 Apr; 42(4):813-7. PubMed ID: 9559788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.